◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksRJF › Revenue

Raymond James Financial Inc. (RJF) Revenue 2006–TTM

DATA UPDATED 2026-07-15

Raymond James Financial Inc. annual revenue for fiscal TTM was $16.4 billion, an increase of 2.8% from $15.9 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

RJF Annual Revenue

Revenue (annual)TTM → 2026-03-312025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-30
Total Revenue$16.4B$15.9B$14.7B$11.5B$11.2B$9.8B$8.1B$7.9B$7.4B$6.4B$5.5B$5.2B$4.9B$4.5B$3.8B$3.3B$3.0B$2.6B$3.2B$3.1B$2.6B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

RJF Quarterly Revenue

Revenue (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$4.3B$4.2B$4.1B$3.8B$3.8B$4.0B$4.0B$3.7B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More RJF metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All RJF financial statements → Interactive RJF charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.